Regulatory T Cells: Master Orchestrators of Immune Tolerance and Tissue Homeostasis

Regulatory T cells (Tregs) are essential for immune tolerance and tissue homeostasis, with recent advancements highlighting their therapeutic potential in treating autoimmune diseases, metabolic disorders, and neurodegeneration. Tregs are adaptive and specialized, capable of maintaining immune balance and promoting tissue repair. Clinical trials have shown the safety and early efficacy of Treg therapies, paving the way for advanced engineering approaches to enhance their antigen-specificity and suppressive capabilities. These developments could shift treatment paradigms from chronic immunosuppression to achieving durable remissions or cures. Challenges remain in optimizing Treg stability, specificity, and scalability, but innovations in synthetic biology and combination therapies are being explored to overcome these limitations. Understanding the influence of environmental factors like the microbiome is crucial for developing resilient Treg therapies.